Clinical Trial Update: Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis [Phase 1]

View source ↗

Summary

Phase 1 pilot study evaluating topical Miltefosine Gel (G-MTF) for cutaneous leishmaniasis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• American Cutaneous Leishmaniasis
• Cutaneous Leishmaniasis

Drugs mentioned

• Miltefosine Gel (G-MTF) (miltefosine)

Snippet

Sponsor: Universidad Industrial de Santander | Conditions: Cutaneous Leishmaniasis, Cutaneous Leishmaniasis, American | Phase 1 | Status: NOT_YET_RECRUITING